Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Adam Crystal, MD, PhD
Tango Therapeutics, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucla Hematology/oncology
Santa Monica, California, United States
- Scri at Healthone
Denver, Colorado, United States
- Florida Cancer Specialists
Sarasota, Florida, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Henry Ford Health System
Detroit, Michigan, United States
- Start Midwest
Grand Rapids, Michigan, United States
- Nyu Langone Hematology Oncology Associates-Mineola
Mineola, New York, United States
- New York University Langone Health
New York, New York, United States
- Sarah Cannon Tennessee Oncology
Nashville, Tennessee, United States
- Us Oncology Investigational Products Center
Dallas, Texas, United States
- the University of Texas Md Anderson Cancer Center
Houston, Texas, United States
- Next Oncology Virginia
Fairfax, Virginia, United States
- Us Oncology Investigational Products Center
Norfolk, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Jun 2023
- Primary completion
- 30 Sept 2026
- Completion
- 30 Sept 2026
- Last update posted
- 6 Jul 2026
- Registered enrollment
- 126
- Registry id
- NCT05887492
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.